Novartis AG Buys Generic Lung Drug Firm Oriel Therapeutics Inc.

Reuters -- Swiss drugmaker Novartis AG has bought privately held U.S. company Oriel Therapeutics to boost its generics portfolio in the multibillion-dollar market for respiratory drugs.

MORE ON THIS TOPIC